2023-07-01 2024-11-30 false Capium Accounts Production 1.1 13036250 2023-07-01 2024-11-30 13036250 bus:AbridgedAccounts 2023-07-01 2024-11-30 13036250 bus:FRS102 2023-07-01 2024-11-30 13036250 bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-11-30 13036250 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-11-30 13036250 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-11-30 13036250 2023-07-01 2024-11-30 13036250 2024-11-30 13036250 bus:RegisteredOffice 2023-07-01 2024-11-30 13036250 core:WithinOneYear 2024-11-30 13036250 core:AfterOneYear 2024-11-30 13036250 1 2023-07-01 2024-11-30 13036250 bus:Director1 2023-07-01 2024-11-30 13036250 bus:Director1 2024-11-30 13036250 bus:Director1 2022-12-01 2023-06-30 13036250 2022-12-01 13036250 bus:LeadAgentIfApplicable 2023-07-01 2024-11-30 13036250 2022-12-01 2023-06-30 13036250 2023-06-30 13036250 core:WithinOneYear 2023-06-30 13036250 core:AfterOneYear 2023-06-30 13036250 bus:EntityAccountantsOrAuditors 2022-12-01 2023-06-30 13036250 bus:OrdinaryShareClass1 2023-07-01 2024-11-30 13036250 bus:OrdinaryShareClass1 2024-11-30 13036250 bus:OrdinaryShareClass1 2022-12-01 2023-06-30 13036250 bus:OrdinaryShareClass1 2023-06-30 13036250 core:ComputerEquipment 2023-07-01 2024-11-30 13036250 core:ComputerEquipment 2024-11-30 13036250 core:ComputerEquipment 2023-06-30 13036250 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-11-30 13036250 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-06-30 13036250 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 13036250 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 13036250 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-11-30 13036250 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-11-30 13036250 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-11-30 13036250 core:Non-currentFinancialInstruments 2024-11-30 13036250 core:Non-currentFinancialInstruments 2023-06-30 13036250 core:ShareCapital 2024-11-30 13036250 core:ShareCapital 2023-06-30 13036250 core:RetainedEarningsAccumulatedLosses 2024-11-30 13036250 core:RetainedEarningsAccumulatedLosses 2023-06-30 13036250 dpl:Item1 2023-07-01 13036250 dpl:Item1 2024-11-30 13036250 dpl:Item1 2022-12-01 13036250 dpl:Item1 2023-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13036250


 

 

 

C64 CLINICS LTD



Abridged Accounts
 


Period of accounts

Start date: 01 July 2023

End date: 30 November 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 3,336    2,780 
3,336    2,780 
Current assets      
Debtors 20,886   
Cash at bank and in hand 91,301    125,701 
112,187    125,701 
Creditors: amount falling due within one year (29,340)   (61,663)
Net current assets 82,847    64,038 
 
Total assets less current liabilities 86,183    66,818 
Net assets 86,183    66,818 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account 86,083    66,718 
Shareholders' funds 86,183    66,818 
 


For the period ended 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 29 May 2025 and were signed by:


-------------------------------
NIRANJAN SRIRAM BALACHANDRAN
Director
1
General Information
C64 CLINICS LTD is a private company, limited by shares, registered in , registration number 13036250, registration address 40,Kerria way, West end village, WOKING, GU24 9XB.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 18 Reducing Balance
2.

Average number of employees


Average number of employees during the period was 2 (2023 : 2).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 July 2023 3,399    3,399 
Additions 1,373    1,373 
Disposals  
At 30 November 2024 4,772    4,772 
Depreciation
At 01 July 2023 619    619 
Charge for period 817    817 
On disposals  
At 30 November 2024 1,436    1,436 
Net book values
Closing balance as at 30 November 2024 3,336    3,336 
Opening balance as at 01 July 2023 2,780    2,780 


4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
100 Class A shares of £1.00 each 100    100 
100    100 

2